Interleukin 2 production in B cell chronic lymphocytic leukemia

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Interleukin 2 (IL 2) is a critical cytokine for immune response.
• B cell chronic lymphocytic leukemia (B-CLL) is characterized by abnormal lymphocytes.
• Altered cytokine production is implicated in the pathogenesis of B-CLL.

Purpose of the Study:

• To investigate Interleukin 2 (IL 2) production in patients with active untreated B cell chronic lymphocytic leukemia (B-CLL).
• To compare IL 2 synthesis between B-CLL patients and healthy donors.
• To elucidate the role of T cells and non-T cells in IL 2 production in B-CLL.

Main Methods:

• Phytohemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PBMCs) from 22 B-CLL patients and 15 healthy donors were analyzed.
• IL 2 production was measured and normalized to T cell numbers and blood volume.
• Experiments involved cell mixing (T cells with non-T cells) and analysis of suppressor cell activity.

Main Results:

• B-CLL PBMCs produced significantly higher levels of IL 2 per T cell and per volume of blood compared to healthy controls.
• IL 2 production in healthy controls increased with irradiation or indomethacin, but not in B-CLL PBMCs, suggesting a lack of suppressor cells.
• B-CLL non-T cells (leukemic B cells) enhanced IL 2 production by T cells more effectively than normal non-T cells.

Conclusions:

• Patients with B-CLL exhibit dysregulated IL 2 production, with enhanced activity per T cell and potentially due to the loss of suppressor cell function.
• B-CLL leukemic B cells play an active role in modulating IL 2 production.
• The findings suggest novel mechanisms contributing to immune dysfunction in B-CLL.